Predictors of hypoglycemia avoidance in a randomized controlled rtCGM trial (HypoDE)
Hermanns, Norbert; Heinemann, Lutz; Freckmann, Guido; u. a. (2018): Predictors of hypoglycemia avoidance in a randomized controlled rtCGM trial (HypoDE), in: Diabetes, Alexandria, Va: American Diabetes Association, Jg. 67, Nr. Suppl. 1, S. A79 (298-OR), doi: 10.2337/db18-298-OR.
Details
- Faculty/Chair
- Faculty/Professorship
- Author
- Heinemann, LutzFreckmann, GuidoWaldenmaier, Delia
- Title of the Journal
- Diabetes
- ISSN
- 0012-1797
- Corporate Body
- American Diabetes Association
- Publisher Information
- American Diabetes Association : Alexandria, Va
- Year of publication
- 2018
- Volume
- 67
- Issue
- Suppl. 1
- Language
- English
- Remark
Abstract:
The HypoDE study, a randomized multi-center trial, showed that rtCGM use reduces the number of low glucose events (<55 mg/dl for at least 20 minutes) per 28 days from 10.4 to 3.4 events compared to SMBG (13.5 to 13.2 events) in MDI-treated type 1 diabetic patients with hypoglycemia problems. In this post-hoc analysis, we analyzed which baseline variables predict successful reduction of low glucose events. The criterion was a reduction to 0 events or by 50% from baseline. In a block-wise, multivariate logistic regression, demographic and medical variables, patient-reported-outcomes, biochemical hypoglycemia at baseline (based on 4-week masked rtCGM use), hours per day in time in range and hyperglycemia, and use of rtCGM were used as predictors. Model fit of the block-wise regression suggests that none of the baseline characteristics did predict hypoglycemia avoidance. However, entering use of rtCGM led to a rise of Nagelkerke´s R² from 0.061 to 0.331. This indicates that rtCGM use was the most important predictor for hypoglycemia avoidance. In the CGM Group, 76.1% of the patients compared to 26.3% in the Control group could avoid hypoglycemic events (Odds ratio 9.8, 95% CI 4.2 to 23.0). This suggests that rtCGM use is effective in patients with type 1 diabetes and hypoglycemia problems regardless of diabetes duration, glycemic control, severity of hypoglycemia problems, and exposure to biochemical hypoglycemia at baseline.
- DOI
- URL
- Peer Reviewed
- yes
- International Distribution
- yes
- Open Access Journal
- no
- Type
- Article
- URI
- Activation date
- 2020-01-15